Publications by authors named "R P Cambria"
Objective: Thoracic endovascular repair (TEVAR) has become the treatment of choice for acute, complicated type B aortic dissections. The purpose of this study was to evaluate the 5-year outcomes of the GORE TAG 08-01 study on TEVAR for acute, complicated type B aortic dissections using the Conformable GORE® TAG® Thoracic Endoprosthesis (CTAG), and to establish if late aortic complications are avoided and remodeling is sustained.
Methods: From January 2010 to February 2017, 50 patients with acute, complicated type B aortic dissections were enrolled from 26 sites in the U.
Article Synopsis
- - A case study outlines the treatment of a rare pancreaticoduodenal artery aneurysm (PDAA) in a 60-year-old woman with a unique anatomy—she had a hypoplastic celiac artery and blood supply coming from a dilated superior mesenteric artery.
- - The patient underwent open surgical reconstruction, which involved resecting the PDAA and reconstructing the pancreaticoduodenal artery, leading to successful blood flow restoration during and after surgery.
- - The surgical intervention was effective; the patient recovered well and was discharged five days post-op with normal liver function tests, indicating a promising management strategy for similar cases.
Objective: The use of local or regional anesthesia (LRA) is encouraged during transcarotid artery revascularization (TCAR) because the procedure is performed through a small incision. LRA permits neurologic evaluation during the procedure and may reduce periprocedural cardiac morbidity compared with general anesthesia (GA). There is limited and conflicting information regarding the preferred anesthesia to use during TCAR.
View Article and Find Full Text PDFAim: The present work reports updated oncological results and patients-reported outcomes at 5 years of phase II trial "Short-term high precision RT for early prostate cancer with SIB to the dominant intraprostatic lesion (DIL) for patients with early-stage PCa".
Methods: Data from patients enrolled within AIRC IG-13218 (NCT01913717) trial were analyzed. Clinical and GU/GI toxicity assessment and PSA measurements were performed every 3 months for at least 2 years after RT end.
Purpose: To report the results involving post-operative interventional radiotherapy (POIRT) in a homogenous cohort of patients affected by keloid and treated at a single institution with the same fractionation schedule.
Patients And Methods: Inclusion criteria were: surgery with a histopathological diagnosis of keloid, subsequent high-dose rate interventional radiotherapy (HDR-IRT)-12 Gy in 4 fractions (3 Gy/fr) twice a day-and follow-up period ≥ 24 months.
Results: One-hundred and two patients and a total of 135 keloids were eligible for the analyses.